PT1119351E - Utilizacao de derivados de catecol como inibidores de proteinases - Google Patents

Utilizacao de derivados de catecol como inibidores de proteinases

Info

Publication number: PT1119351E
Authority: PT; Portugal
Prior art keywords: derivatives; catecol; utilization; protein inhibitors; inhibitors
Prior art date: 1998-10-02

Application number

PT99969932T

Other languages

English (en)

Inventor

Johannes Schneider

Stephan Wnendt

Zimmer Dr Oswald

Strassburger Prof Dr Wolfgang

Ulrich Seipp

Norbert Ulbrich

Heidi Hecker-Kia

Bernd Zimmermann

Original Assignee

Gruenenthal Gmbh

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-10-02

Filing date

1999-09-23

Publication date

2003-09-30

1999-09-23 Application filed by Gruenenthal Gmbh filed Critical Gruenenthal Gmbh

2003-09-30 Publication of PT1119351E publication Critical patent/PT1119351E/pt

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/05—Phenols
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Physical Education & Sports Medicine (AREA)
Orthopedic Medicine & Surgery (AREA)
Rheumatology (AREA)
Epidemiology (AREA)
Dermatology (AREA)
Oncology (AREA)
Immunology (AREA)
Ophthalmology & Optometry (AREA)
Heart & Thoracic Surgery (AREA)
Urology & Nephrology (AREA)
Cardiology (AREA)
Toxicology (AREA)
Vascular Medicine (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

PT99969932T 1998-10-02 1999-09-23 Utilizacao de derivados de catecol como inibidores de proteinases PT1119351E (pt)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
DE19845372A DE19845372A1 (de)	1998-10-02	1998-10-02	Verwendung von Katecholderivaten als Proteinaseninhibitoren

Publications (1)

Publication Number	Publication Date
PT1119351E true PT1119351E (pt)	2003-09-30

Family

ID=7883162

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PT99969932T PT1119351E (pt)	1998-10-02	1999-09-23	Utilizacao de derivados de catecol como inibidores de proteinases

Country Status (14)

Country	Link
US (1)	US6509368B1 (pt)
EP (1)	EP1119351B1 (pt)
JP (1)	JP2002526404A (pt)
AT (1)	ATE238781T1 (pt)
AU (1)	AU766379B2 (pt)
CA (1)	CA2346019A1 (pt)
DE (2)	DE19845372A1 (pt)
DK (1)	DK1119351T3 (pt)
ES (1)	ES2198992T3 (pt)
HK (1)	HK1039451B (pt)
HU (1)	HUP0104162A3 (pt)
NZ (1)	NZ510820A (pt)
PT (1)	PT1119351E (pt)
WO (1)	WO2000019989A2 (pt)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
MXPA04000695A (es)	2001-07-23	2005-08-26	Galileo Pharmaceuticals Inc	Compuestos citoprotectores, formulaciones farmaceuticas y cosmeticas y metodos.

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1982003729A1 (en) *	1981-04-08	1982-10-28	Lo Gorton	Electrode for the electrochemical regeneration of co-enzyme,a method of making said electrode,and the use thereof
DE3518655A1 (de)	1985-05-24	1986-11-27	Grünenthal GmbH, 5190 Stolberg	Neue phenolderivate, diese enthaltende arzneimittel und verfahren zur herstellung dieser verbindungen und arzneimittel
WO1988001509A1 (en) *	1986-08-25	1988-03-10	Chemex Pharmaceuticals, Inc.	Pharmacologically active compositions of catecholic butanes with zinc
US5409690A (en) *	1993-06-23	1995-04-25	Chemex Pharmaceuticals, Inc.	Treatment of multidrug resistant diseases in cancer cell by potentiating with masoprocol
WO1996031206A2 (en) *	1995-04-07	1996-10-10	Warner-Lambert Company	Flavones and coumarins as agents for the treatment of atherosclerosis
EP0850055B1 (en) *	1995-09-11	2005-06-29	Osteoarthritis Sciences, Inc.	Protein tyrosine kinase inhibitors for treating osteoarthritis
WO1999008672A1 (en) *	1997-08-15	1999-02-25	Shire International Licensing Bv	Use of cholinesterase inhibitor for treating diseases associated with proteolytic enzyme activity
JP2886523B1 (ja) *	1998-01-20	1999-04-26	岐阜県	ガン転移抑制剤及びコラゲナーゼ活性抑制剤

1998
- 1998-10-02 DE DE19845372A patent/DE19845372A1/de not_active Ceased
1999
- 1999-09-23 DK DK99969932T patent/DK1119351T3/da active
- 1999-09-23 HU HU0104162A patent/HUP0104162A3/hu unknown
- 1999-09-23 DE DE59905355T patent/DE59905355D1/de not_active Expired - Fee Related
- 1999-09-23 HK HK02100704.5A patent/HK1039451B/zh not_active IP Right Cessation
- 1999-09-23 AT AT99969932T patent/ATE238781T1/de not_active IP Right Cessation
- 1999-09-23 PT PT99969932T patent/PT1119351E/pt unknown
- 1999-09-23 ES ES99969932T patent/ES2198992T3/es not_active Expired - Lifetime
- 1999-09-23 AU AU59813/99A patent/AU766379B2/en not_active Ceased
- 1999-09-23 US US09/806,466 patent/US6509368B1/en not_active Expired - Fee Related
- 1999-09-23 WO PCT/EP1999/007068 patent/WO2000019989A2/de not_active Ceased
- 1999-09-23 JP JP2000573350A patent/JP2002526404A/ja not_active Withdrawn
- 1999-09-23 CA CA002346019A patent/CA2346019A1/en not_active Abandoned
- 1999-09-23 NZ NZ510820A patent/NZ510820A/en unknown
- 1999-09-23 EP EP99969932A patent/EP1119351B1/de not_active Expired - Lifetime

Also Published As

Publication number	Publication date
CA2346019A1 (en)	2000-04-13
HK1039451A1 (zh)	2002-04-26
EP1119351B1 (de)	2003-05-02
NZ510820A (en)	2004-01-30
HK1039451B (zh)	2003-08-22
AU5981399A (en)	2000-04-26
DE59905355D1 (de)	2003-06-05
DE19845372A1 (de)	2000-04-20
HUP0104162A3 (en)	2002-08-28
DK1119351T3 (da)	2003-08-18
WO2000019989A3 (de)	2000-11-09
EP1119351A2 (de)	2001-08-01
US6509368B1 (en)	2003-01-21
ES2198992T3 (es)	2004-02-01
JP2002526404A (ja)	2002-08-20
HUP0104162A2 (hu)	2002-05-29
ATE238781T1 (de)	2003-05-15
AU766379B2 (en)	2003-10-16
WO2000019989A2 (de)	2000-04-13

Publication	Publication Date	Title
ES2183331T3 (es)	2003-03-16	Inhibidores de sulfamida-metaloproteasa.
ES2182234T3 (es)	2003-03-01	Inhibidores de metaloproteasa.
ATE233274T1 (de)	2003-03-15	Oxyiminopregnancarbolactone
TR200101709T2 (tr)	2001-12-21	İltihabik hastalıkların tedavisinde yararlı olan bileşikler
BR0013966A (pt)	2004-06-15	Compostos espiroeterocìclicos úteis como inibidores reversìveis de proteases de cisteìna
TR199901905T2 (xx)	1999-10-21	2-(P�rin-9-il)-tetrahidrofuran-3,4-diol t�revleri.
NO990667D0 (no)	1999-02-12	Depeptid-benzamidin som kinogenase-inhibitor
HN2001000217A (es)	2002-06-13	Nuevos tiadiazoles y oxadiazoles y su uso como inhibidores de fosfodiesterasa - 7
DE69919700D1 (de)	2004-09-30	Überbrückte indenopyrrolocarbazole
DE60021381D1 (de)	2005-08-25	Chinonverbindungen zur behandlung von krankheiten
SE9801494D0 (sv)	1998-04-28	Novel use
SE9903290D0 (sv)	1999-09-15	Novel compounds
ATE320422T1 (de)	2006-04-15	Metalloproteinase inhibitoren
HRP20050382B1 (hr)	2013-09-30	Novi pirimidin-4,6-dikarboksamidi za selektivnu inhibiciju kolagenaza
DK1204659T3 (da)	2004-04-05	Serotonerge benzofuraner
PT1119351E (pt)	2003-09-30	Utilizacao de derivados de catecol como inibidores de proteinases
ATE269313T1 (de)	2004-07-15	Tryptase-inhibitoren
PT1244614E (pt)	2004-10-29	Inibidores de triptase
DE69703115D1 (de)	2000-10-19	Zwischenprodukte um 2-imidazolin-5onederivate herzustellen.
BR9808210A (pt)	2000-05-16	Befeniloxazolinas dissubstituìdas
ATE213236T1 (de)	2002-02-15	Substituierte benzyloxyimino-verbindungen
PT1104419E (pt)	2002-09-30	Derivados de azabicicloheptano substituidos no azoto sua preparacao e utilizacao
PT1358182E (pt)	2004-12-31	Derivados de diazocinas e sua utilizacao como inibidores de triptase
PT1140932E (pt)	2004-08-31	Derivados de 1,8-benzonaftiridina
TR199902097A2 (xx)	2000-03-21	Mikrobial transformasyon.